Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
AbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.M...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479 |
_version_ | 1797324144314941440 |
---|---|
author | Yanting Hu Guoliang Xue Xinyu Liang Zhichao Li Nan Wang Pikun Cao Gang Wang Haitao Zhang Xiaohuan Zheng Aiguang Wang Wenhua Zhao Cuiping Han Zhigang Wei Xin Ye |
author_facet | Yanting Hu Guoliang Xue Xinyu Liang Zhichao Li Nan Wang Pikun Cao Gang Wang Haitao Zhang Xiaohuan Zheng Aiguang Wang Wenhua Zhao Cuiping Han Zhigang Wei Xin Ye |
author_sort | Yanting Hu |
collection | DOAJ |
description | AbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.Methods Between May 2020 and April 2022, 71 patients with 71 RML pulmonary nodules underwent 71 MWA sessions. To comparison, 142 patients with 142 pulmonary nodules in non-RML were selected using propensity score matching. The technical success, technique efficacy, complications, and associated factors were analyzed. The duration of the procedure and post-ablation hospital stay were also recorded.Results Technical success was achieved in 100% of all patients. There were no significant differences in technique efficacy rates between the RML and non-RML groups (97.2% vs. 95.1%, p = 0.721). However, both major (47.9% vs. 19.7%, p < 0.001) and minor (26.8% vs. 11.3%, p = 0.004) pneumothorax were more common in the RML group than non-RML group. MWA for RML pulmonary nodules was identified as an independent risk factor for pneumothorax (p < 0.001). The duration of procedures (51.7 min vs. 35.3 min, p < 0.001) and post-ablation hospital stays (4.7 days vs. 2.8 days, p < 0.001) were longer in the RML group than non-RML group.Conclusions CT-guided MWA for RML pulmonary nodules showed comparable efficacy compared with other lobes, but posed a higher risk of pneumothorax complications, necessitating longer MWA procedure times and extended hospital stays. |
first_indexed | 2024-03-08T05:45:57Z |
format | Article |
id | doaj.art-a64b001bd89a41e9a753d55261defbd8 |
institution | Directory Open Access Journal |
issn | 0265-6736 1464-5157 |
language | English |
last_indexed | 2024-03-08T05:45:57Z |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | International Journal of Hyperthermia |
spelling | doaj.art-a64b001bd89a41e9a753d55261defbd82024-02-05T10:41:22ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2307479Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control studyYanting Hu0Guoliang Xue1Xinyu Liang2Zhichao Li3Nan Wang4Pikun Cao5Gang Wang6Haitao Zhang7Xiaohuan Zheng8Aiguang Wang9Wenhua Zhao10Cuiping Han11Zhigang Wei12Xin Ye13Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaAbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.Methods Between May 2020 and April 2022, 71 patients with 71 RML pulmonary nodules underwent 71 MWA sessions. To comparison, 142 patients with 142 pulmonary nodules in non-RML were selected using propensity score matching. The technical success, technique efficacy, complications, and associated factors were analyzed. The duration of the procedure and post-ablation hospital stay were also recorded.Results Technical success was achieved in 100% of all patients. There were no significant differences in technique efficacy rates between the RML and non-RML groups (97.2% vs. 95.1%, p = 0.721). However, both major (47.9% vs. 19.7%, p < 0.001) and minor (26.8% vs. 11.3%, p = 0.004) pneumothorax were more common in the RML group than non-RML group. MWA for RML pulmonary nodules was identified as an independent risk factor for pneumothorax (p < 0.001). The duration of procedures (51.7 min vs. 35.3 min, p < 0.001) and post-ablation hospital stays (4.7 days vs. 2.8 days, p < 0.001) were longer in the RML group than non-RML group.Conclusions CT-guided MWA for RML pulmonary nodules showed comparable efficacy compared with other lobes, but posed a higher risk of pneumothorax complications, necessitating longer MWA procedure times and extended hospital stays.https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479Right middle lobepulmonary nodulemicrowave ablationcomplicationpneumothorax |
spellingShingle | Yanting Hu Guoliang Xue Xinyu Liang Zhichao Li Nan Wang Pikun Cao Gang Wang Haitao Zhang Xiaohuan Zheng Aiguang Wang Wenhua Zhao Cuiping Han Zhigang Wei Xin Ye Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study International Journal of Hyperthermia Right middle lobe pulmonary nodule microwave ablation complication pneumothorax |
title | Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study |
title_full | Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study |
title_fullStr | Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study |
title_full_unstemmed | Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study |
title_short | Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study |
title_sort | computed tomography guided microwave ablation for right middle lobe pulmonary nodules a retrospective single center case control study |
topic | Right middle lobe pulmonary nodule microwave ablation complication pneumothorax |
url | https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479 |
work_keys_str_mv | AT yantinghu computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT guoliangxue computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT xinyuliang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT zhichaoli computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT nanwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT pikuncao computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT gangwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT haitaozhang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT xiaohuanzheng computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT aiguangwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT wenhuazhao computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT cuipinghan computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT zhigangwei computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy AT xinye computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy |